Overview Preoperative levosimendán and Hip Fracture Status: Completed Trial end date: 2019-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate whether preoperative optimization with levosimendan in heart failure patients undergoing hip fracture surgery improves haemodynamic and tissue perfusion parameters. Details Lead Sponsor: Hospital Universitario de CanariasCollaborator: Orion Corporation, Orion PharmaTreatments: Simendan